Rayhaneh Afjei

845 total citations
12 papers, 687 citations indexed

About

Rayhaneh Afjei is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Rayhaneh Afjei has authored 12 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biomedical Engineering. Recurrent topics in Rayhaneh Afjei's work include RNA Interference and Gene Delivery (4 papers), Cancer-related Molecular Pathways (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Rayhaneh Afjei is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Cancer-related Molecular Pathways (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Rayhaneh Afjei collaborates with scholars based in United States, France and Japan. Rayhaneh Afjei's co-authors include Ramasamy Paulmurugan, Tarik F. Massoud, Uday Kumar Sukumar, Sanjiv S. Gambhir, Elise Robinson, Yitian Zeng, Frezghi Habte, Rajendran JC Bose, Robert Sinclair and Husam Babikir and has published in prestigious journals such as ACS Nano, Biomaterials and Scientific Reports.

In The Last Decade

Rayhaneh Afjei

12 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rayhaneh Afjei United States 11 468 231 225 144 63 12 687
Alexander Ewe Germany 18 628 1.3× 216 0.9× 189 0.8× 162 1.1× 46 0.7× 34 819
Damiano Librizzi Germany 14 663 1.4× 122 0.5× 91 0.4× 147 1.0× 57 0.9× 49 1.0k
Kazutaka Nishina Japan 12 698 1.5× 89 0.4× 169 0.8× 143 1.0× 41 0.7× 23 882
Hannah J. Vaughan United States 8 453 1.0× 253 1.1× 84 0.4× 257 1.8× 59 0.9× 14 739
Noemi Arrighetti Italy 14 548 1.2× 187 0.8× 200 0.9× 128 0.9× 42 0.7× 26 790
Xin Zeng China 15 720 1.5× 102 0.4× 173 0.8× 134 0.9× 31 0.5× 30 966
S.‐Ja Tseng Taiwan 18 327 0.7× 249 1.1× 76 0.3× 169 1.2× 101 1.6× 30 699
Hailiang Deng China 8 289 0.6× 139 0.6× 75 0.3× 146 1.0× 61 1.0× 9 540
Noriyuki Maeda Japan 16 442 0.9× 238 1.0× 93 0.4× 289 2.0× 55 0.9× 20 674
Samuel A. Jensen United States 4 535 1.1× 134 0.6× 89 0.4× 144 1.0× 64 1.0× 4 708

Countries citing papers authored by Rayhaneh Afjei

Since Specialization
Citations

This map shows the geographic impact of Rayhaneh Afjei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rayhaneh Afjei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rayhaneh Afjei more than expected).

Fields of papers citing papers by Rayhaneh Afjei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rayhaneh Afjei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rayhaneh Afjei. The network helps show where Rayhaneh Afjei may publish in the future.

Co-authorship network of co-authors of Rayhaneh Afjei

This figure shows the co-authorship network connecting the top 25 collaborators of Rayhaneh Afjei. A scholar is included among the top collaborators of Rayhaneh Afjei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rayhaneh Afjei. Rayhaneh Afjei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Afjei, Rayhaneh, Uday Kumar Sukumar, Mallesh Pandrala, et al.. (2022). A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers. 14(24). 6120–6120. 15 indexed citations
2.
Sukumar, Uday Kumar, Rayhaneh Afjei, Katherine W. Ferrara, Tarik F. Massoud, & Ramasamy Paulmurugan. (2021). Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle. ACS Nano. 15(11). 17582–17601. 66 indexed citations
3.
Chowdhury, Sayan Mullick, Taehwa Lee, Huaijun Wang, et al.. (2020). Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo. Journal of Controlled Release. 321. 272–284. 53 indexed citations
4.
Nishihara, Ryo, Ramasamy Paulmurugan, Takahiro Nakajima, et al.. (2019). Highly bright and stable NIR-BRET with blue-shifted coelenterazine derivatives for deep-tissue imaging of molecular events in vivo. Theranostics. 9(9). 2646–2661. 33 indexed citations
5.
6.
Babikir, Husam, Rayhaneh Afjei, Ramasamy Paulmurugan, & Tarik F. Massoud. (2019). EXTH-30. PRECEDING p53 STABILIZATION USING DOXORUBICIN AUGMENTS PRIMA-1-MEDIATED p53 REFOLDING AND INCREASED CELLULAR APOPTOSIS: EVALUATION OF A SEQUENTIAL COMBINATION THERAPY AGAINST GLIOBLASTOMA. Neuro-Oncology. 21(Supplement_6). vi88–vi88. 1 indexed citations
7.
Bose, Rajendran JC, Uday Kumar Sukumar, Yitian Zeng, et al.. (2018). Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents. ACS Nano. 12(11). 10817–10832. 189 indexed citations
8.
Babikir, Husam, Rayhaneh Afjei, Ramasamy Paulmurugan, & Tarik F. Massoud. (2018). Restoring guardianship of the genome: Anticancer drug strategies to reverse oncogenic mutant p53 misfolding. Cancer Treatment Reviews. 71. 19–31. 10 indexed citations
9.
Paulmurugan, Ramasamy, Rayhaneh Afjei, Thillai V. Sekar, Husam Babikir, & Tarik F. Massoud. (2018). A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells. Oncotarget. 9(30). 21495–21511. 11 indexed citations
10.
11.
Malhotra, Meenakshi, Jeyarama S. Ananta, Rammohan Devulapally, et al.. (2018). Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model. Oncotarget. 9(30). 21478–21494. 52 indexed citations
12.
Hori, Sharon S., Rayhaneh Afjei, Thillai V. Sekar, et al.. (2017). Engineering Intracellularly Retained Gaussia Luciferase Reporters for Improved Biosensing and Molecular Imaging Applications. ACS Chemical Biology. 12(9). 2345–2353. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Ewe Breakdown of academic impact, for papers by Damiano Librizzi Breakdown of academic impact, for papers by Kazutaka Nishina Breakdown of academic impact, for papers by Hannah J. Vaughan Breakdown of academic impact, for papers by Noemi Arrighetti Breakdown of academic impact, for papers by Xin Zeng Breakdown of academic impact, for papers by S.‐Ja Tseng Breakdown of academic impact, for papers by Hailiang Deng Breakdown of academic impact, for papers by Noriyuki Maeda Breakdown of academic impact, for papers by Samuel A. Jensen
Rankless by CCL
2026